Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 5/2013

01-05-2013 | Letter to the Editors

High-dose praziquantel therapy for cerebral sparganosis

Authors: Roman R. Gonzenbach, Yoon Kong, Bernhard Beck, Alfred Buck, Michael Weller, Alexander Semmler

Published in: Journal of Neurology | Issue 5/2013

Login to get access

Excerpt

Dear Sirs, …
Literature
1.
Deng L, Xiong P, Qian S (2011) Diagnosis and stereotactic aspiration treatment of cerebral sparganosis: summary of 11 cases. J Neurosurg 114(5):1421–1425PubMed
2.
Kim DG, Paek SH, Chang KH, Wang KC, Jung HW, Kim HJ, Chi JG, Choi KS, Han DH (1996) Cerebral sparganosis: clinical manifestations, treatment, and outcome. J Neurosurg 85(6):1066–1071PubMedCrossRef
3.
Torres JR, Noya OO, Noya BA, Mouliniere R, Martinez E (1981) Treatment of proliferative sparganosis with mebendazole and praziquantel. Trans R Soc Trop Med Hyg 75(6):846–847PubMedCrossRef
4.
Sotelo J, Jung H (1998) Pharmacokinetic optimisation of the treatment of neurocysticercosis. Clin Pharmacokinet 34(6):503–515PubMedCrossRef
5.
Kong Y, Kang SY, Cho SY (1991) Single step purification of potent antigenic protein from sparganum by gelatin-affinity chromatography. Kisaengchunghak Chapchi 29(1):1–7PubMed
6.
Song T, Wang WS, Zhou BR, Mai WW, Li ZZ, Guo HC, Zhou F (2007) CT and MR characteristics of cerebral sparganosis. AJNR Am J Neuroradiol 28(9):1700–1705PubMedCrossRef
7.
Chang KH, Chi JG, Cho SY, Han MH, Han DH, Han MC (1992) Cerebral sparganosis: analysis of 34 cases with emphasis on CT features. Neuroradiology 34(1):1–8PubMedCrossRef
Metadata
Title
High-dose praziquantel therapy for cerebral sparganosis
Authors
Roman R. Gonzenbach
Yoon Kong
Bernhard Beck
Alfred Buck
Michael Weller
Alexander Semmler
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 5/2013
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-6901-7

Other articles of this Issue 5/2013

Journal of Neurology 5/2013 Go to the issue

Original Communication

Cognitive outcome of survivors of space-occupying hemispheric infarction

Original Communication

Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions

Original Communication

Early sleep apnea screening on a stroke unit is feasible in patients with acute cerebral ischemia

Original Communication

Long-term outcome in patients with Guillain–Barré syndrome requiring mechanical ventilation

Pioneers in Neurology

Anders Retzius (1796–1860)

Letter to the Editors

Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration